HIGHLIGHTS
- who: Beatriz Aragón-Aranda from the (UNIVERSITY) have published the paper: Rev1 wbdR tagged vaccines against Brucella ovis, in the Journal: (JOURNAL)
- what: The aim of this research is to investigate an alternative to circumvent the serological diagnosis problems caused by the Rev1 vaccine while keeping its good attenuation and protection characteristics. The authors the experiments carried out in the mouse model as a first step to investigate the validity of this approach. The results presented in this work demonstrate that the O-PS of vaccine Rev1 can be antigenically tagged by genomic insertion . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.